Company profile
biote Corp.
NASDAQ: BTMD · Healthcare · Medical - Care Facilities
#292 of 1,420 Healthcare companies by revenue37th-percentile growth
EA Score
63CFH 79DQ 44GM 58SS 51
v0.1 · 65/100 weight · provisional
↑ return on assets, operating margin · ↓ listing tenure, disclosure history
Methodology →Revenue TTM
$188.2M
Rev growth YoY (TTM)
-5.6%
Net income (FY)
$27.0M
Employees
223
as of 2026-08-18
Market cap
$58.4M
as of 2026-08-18
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$192.2M$192.2M2025
Net income$27.0M$27.0M2025
Operating income$35.6M$35.6M2025
Total assets$107.6M$107.6M2025
Liabilities$158.0M$158.0M2025
Equity-$58.5M-$58.5M2025
Revenue trend
FY2022 – FY2025 · USD
FY22
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Product Revenue78%
Dietary Supplements18%
Service Revenue2%
Other Service Revenue1%
Training Service Revenue0%
By geography
UNITED STATES99%
Non-US1%
The read
What is biote Corp.’s revenue?
biote Corp. booked $192.2M in FY2025 revenue, contracting 2.5% year over year — slower than 63% of Healthcare companies we track, at a 14.1% net margin.
Peers · Healthcare
SI-BONE, Inc.70BStrata Critical Medical, Inc.60CLifeMD, Inc.73BRhythm Pharmaceuticals, Inc.60CMaravai LifeSciences Holdings, Inc.53DStoke Therapeutics, Inc.60CNeighbors
Dallas →Key facts
CEORobert C. Peterson
SectorHealthcare
IndustryMedical - Care Facilities
HeadquartersIrving, TX
ExchangeNASDAQ: BTMD
Employees223
IPO date2021-04-28
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.